Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
53,136,600
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
35,697,467
-
Shares change
-
-736,263
-
Total reported value, excl. options
-
$161,353,347
-
Value change
-
-$6,004,486
-
Put/Call ratio
-
1.43%
-
Number of buys
-
42
-
Number of sells
-
-36
-
Price
-
$4.52
Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q1 2023
100 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q1 2023.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,697,467 shares
of 53,136,600 outstanding shares and own 67.18% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9,699,925 shares), FMR LLC (6,129,441 shares), Vivo Capital, LLC (4,220,048 shares), ORBIMED ADVISORS LLC (2,871,000 shares), BlackRock Inc. (1,668,624 shares), Logos Global Management LP (1,500,000 shares), BRAIDWELL LP (1,249,900 shares), VANGUARD GROUP INC (1,035,539 shares), EVENTIDE ASSET MANAGEMENT, LLC (664,829 shares), and Cormorant Asset Management, LP (612,079 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.